Heat shock protein 27 attenuates neointima formation and accelerates reendothelialization after arterial injury and stent implantation: Importance of vascular endothelial growth factor up-regulation

FASEB Journal

Volumn 28, Issue 2, 2014, Pages 594-602

  Ma, Xiaoli ^a   Hibbert, Benjamin ^a   McNulty, Melissa ^a   Hu, Tieqiang ^a   Zhao, Xiaoling ^a   Ramirez, F Daniel ^a   Simard, Trevor ^a   De Belleroche, Jacqueline S ^b   O'Brien, Edward R ^a,c  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

Progenitor cell; Restenosis; VEGF

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEAT SHOCK PROTEIN 27; HEPARIN; MESSENGER RNA; POLYMYXIN B; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BARE METAL STENT; BLOOD VESSEL INJURY; CAROTID ARTERY STENT; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; COCULTURE; CONTROLLED STUDY; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; LOADING DRUG DOSE; MALE; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; RECOMBINANT HEAT SHOCK PROTEIN 27 ELUTING STENT; REENDOTHELIALIZATION; RNA ISOLATION; STENT THROMBOSIS; TISSUE GROWTH; UPREGULATION; WOUND CLOSURE; WOUND HEALING; ANIMAL; CAROTID ARTERY; CAROTID ARTERY INJURY; CELL CULTURE; DRUG EFFECT; METABOLISM; RESTENOSIS; STEM CELL; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

PROGENITOR CELL; RESTENOSIS; VEGF;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HSP27 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; NEOINTIMA; RABBITS; REAL-TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84897097371     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-230417     Document Type: Article

References (40)

1. Pourdjabbar, A., Hibbert, B., Simard, T., Ma, X., and O'Brien, E. R. (2011) Pathogenesis of neointima formation following vascular injury. Cardiovasc. Hematol. Disord. Drug Targets 11, 30-39
2. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J. M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967
3. Hirschi, K. K., Ingram, D. A., and Yoder, M. C. (2008) Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 28, 1584-1595
4. Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Bohm, M., and Nickenig, G. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353, 999-1007
5. Assmus, B., Honold, J., Schachinger, V., Britten, M. B., Fischer- Rasokat, U., Lehmann, R., Teupe, C., Pistorius, K., Martin, H., Abolmaali, N. D., Tonn, T., Dimmeler, S., and Zeiher, A. M. (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355, 1222-1232
6. Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., Suselbeck, T., Assmus, B., Tonn, T., Dimmeler, S., and Zeiher, A. M. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355, 1210-1221
7. Hibbert, B., Ma, X., Pourdjabbar, A., Holm, E., Rayner, K., Chen, Y. X., Sun, J., Filion, L., and O'Brien, E. R. (2009) Inhibition of endothelial progenitor cell glycogen synthase kinase-3beta results in attenuated neointima formation and enhanced re-endothelialization after arterial injury. Cardiovasc. Res. 83, 16-23
8. Ma, X., Hibbert, B., Dhaliwal, B., Seibert, T., Chen, Y. X., Zhao, X., and O'Brien, E. R. (2010) Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor. Cardiovasc. Res. 86, 338-345
9. Zhao, Y. D., Courtman, D. W., Deng, Y., Kugathasan, L., Zhang, Q., and Stewart, D. J. (2005) Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ. Res. 96, 442-450
10. Martin-Ventura, J. L., Duran, M. C., Blanco-Colio, L. M., Meilhac, O., Leclercq, A., Michel, J. B., Jensen, O. N., Hernandez- Merida, S., Tunon, J., Vivanco, F., and Egido, J. (2004) Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 110, 2216-2219
11. Miller, H., Poon, S., Hibbert, B., Rayner, K., Chen, Y. X., and O'Brien, E. R. (2005) Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens. Arterioscler. Thromb. Vasc. Biol. 25, e10-e14
12. Rayner, K., Chen, Y. X., Siebert, T., and O'Brien, E. R. (2010) Heat shock protein 27: clue to understanding estrogen-mediated atheroprotection? Trends Cardiovasc. Med. 20, 54-58
13. Rayner, K., Sun, J., Chen, Y. X., McNulty, M., Simard, T., Zhao, X., Wells, D. J., de Belleroche, J., and O'Brien, E. R. (2009) Heat shock protein 27 protects against atherogenesis via an estrogendependent mechanism: role of selective estrogen receptor beta modulation. Arterioscler. Thromb. Vasc. Biol. 29, 1751-1756
14. Rayner, K., Chen, Y. X., McNulty, M., Simard, T., Zhao, X., Wells, D. J., de Belleroche, J., and O'Brien, E. R. (2008) Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Circ. Res. 103, 133-141
15. Mehlen, P., Schulze-Osthoff, K., and Arrigo, A. P. (1996) Small stress proteins as novel regulators of apoptosis: heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J. Biol. Chem. 271, 16510-16514
16. Salari, S., Seibert, T., Chen, Y. X., Hu, T., Shi, C., Zhao, X., Cuerrier, C. M., Raizman, J. E., and O'Brien, E. R. (2013) Extracellular HSP27 acts as a signaling molecule to activate NF-kappaB in macrophages. Cell Stress Chaperones 18, 53-63
17. Chen, H. F., Xie, L. D., and Xu, C. S. (2009) Role of heat shock protein 27 phosphorylation in migration of vascular smooth muscle cells. Mol. Cell. Biochem. 327, 1-6
18. Park, H. K., Park, E. C., Bae, S. W., Park, M. Y., Kim, S. W., Yoo, H. S., Tudev, M., Ko, Y. H., Choi, Y. H., Kim, S., Kim, D. I., Kim, Y. W., Lee, B. B., Yoon, J. B., and Park, J. E. (2006) Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 114, 886-893
19. Seibert, T., Hibbert, B., Chen, Y. X., Rayner, K., Simard, T., Hu, T., Cuerrier, C., Zhao, X., de Belleroche, J., Chow, B., Wilson, K., Hawken, S., and O'Brien, E. R. (2013) Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis. J. Am. Coll. Cardiol. 62, 1446-1454
20. Hibbert, B., Ma, X., Pourdjabbar, A., Simard, T., Rayner, K., Sun, J., Chen, Y. X., Filion, L., and O'Brien, E. R. (2011) Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries. PLoS One 6, e16413
21. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
22. Liang, C. C., Park, A. Y., and Guan, J. L. (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2, 329-333
23. Akbar, M. T., Lundberg, A. M., Liu, K., Vidyadaran, S., Wells, K. E., Dolatshad, H., Wynn, S., Wells, D. J., Latchman, D. S., and de Belleroche, J. (2003) The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J. Biol. Chem. 278, 19956-19965
24. Sata, M., Maejima, Y., Adachi, F., Fukino, K., Saiura, A., Sugiura, S., Aoyagi, T., Imai, Y., Kurihara, H., Kimura, K., Omata, M., Makuuchi, M., Hirata, Y., and Nagai, R. (2000) A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J. Mol. Cell. Cardiol. 32, 2097-2104
25. Chen, Y. X., Ma, X., Whitman, S., and O'Brien, E. R. (2004) Novel antiinflammatory vascular benefits of systemic and stentbased delivery of ethylisopropylamiloride. Circulation 110, 3721-3726
26. Chen, Y. X., and O'Brien, E. R. (2003) Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activity. Can. J. Physiol. Pharmacol. 81, 730-739
27. Cuerrier, C. M., Chen, Y. X., Tremblay, D., Rayner, K., McNulty, M., Zhao, X. L., Kennedy, C. R. J., de Belleroche, J., Pelling, A. E., and O'Brien, E. R. (2013) Chronic over-expression of heat shock protein 27 attenuates atherogenesis and enhances plaque remodeling: a combined histological and mechanical assessment of aortic lesions. PLoS One 8, e55867
28. Kubo, M., Li, T. S., Kurazumi, H., Takemoto, Y., Ohshima, M., Yamamoto, Y., Nishimoto, A., Mikamo, A., Fujimoto, M., Nakai, A., and Hamano, K. (2012) Heat shock factor 1 contributes to ischemia-induced angiogenesis by regulating the mobilization and recruitment of bone marrow stem/progenitor cells. PLoS One 7, e37934
29. Douglas, G., Van Kampen, E., Hale, A. B., McNeill, E., Patel, J., Crabtree, M. J., Ali, Z., Hoerr, R. A., Alp, N. J., and Channon, K. M. (2012) Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification. [E-pub ahead of print] Eur. Heart J. doi: 10.1093/eurheartj/ ehs240
30. Ma, X., Hibbert, B., White, D., Seymour, R., Whitman, S. C., and O'Brien, E. R. (2008) Contribution of recipient-derived cells in allograft neointima formation and the response to stent implantation. PLoS One 3, e1894
31. Mauri, L., Hsieh, W. H., Massaro, J. M., Ho, K. K., D'Agostino, R., and Cutlip, D. E. (2007) Stent thrombosis in randomized clinical trials of drug-eluting stents. N. Engl. J. Med. 356, 1020-1029
32. Garg, S., Serruys, P., Onuma, Y., Dorange, C., Veldhof, S., Miquel-Hebert, K., Sudhir, K., Boland, J., Huber, K., Garcia, E., and te Riele, J. A. M. (2009) 3-Year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (clinical evaluation of the Xience V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC Cardiovasc. Interv. 2, 1190-1198
33. Kirtane, A. J., Leon, M. B., Ball, M. W., Bajwa, H. S., Sketch, J., Coleman, P. S., Stoler, R. C., Papadakos, S., Cutlip, D. E., Mauri, L., and Kandzari, D. E. (2013) The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent. JACC Cardiovasc. Interv. 6, 325-333
34. Leon, M. B., Mauri, L., Popma, J. J., Cutlip, D. E., Nikolsky, E., O'Shaughnessy, C., Overlie, P. A., McLaurin, B. T., Solomon, S. L., Douglas, J., Ball, M. W., Caputo, R. P., Jain, A., Tolleson, T. R., Reen III, B. M., Kirtane, A. J., Fitzgerald, P. J., Thompson, K., and Kandzari, D. E. (2010) A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel- eluting stent in de novo native coronary lesions. 12-Month outcomes from the ENDEAVOR IV trial. J. Am. Coll. Cardiol. 55, 543-554
35. Straume, O., Shimamura, T., Lampa, M. J., Carretero, J., Oyan, A. M., Jia, D., Borgman, C. L., Soucheray, M., Downing, S. R., Short, S. M., Kang, S. Y., Wang, S., Chen, L., Collett, K., Bachmann, I., Wong, K. K., Shapiro, G. I., Kalland, K. H., Folkman, J., Watnick, R. S., Akslen, L. A., and Naumov, G. N. (2012) Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 109, 8699-8704
36. Kato, K., Tokuda, H., Adachi, S., Matsushima-Nishiwaki, R., Yamauchi, J., Natsume, H., Minamitani, C., Mizutani, J., Otsuka, T., and Kozawa, O. (2011) Role of heat shock protein 27 in transforming growth factor-beta-stimulated vascular endothelial growth factor release in osteoblasts. Int. J. Mol. Med. 27, 423-428
37. Keezer, S. M., Ivie, S. E., Krutzsch, H. C., Tandle, A., Libutti, S. K., and Roberts, D. D. (2003) Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res. 63, 6405-6412
38. Hutter, R., Carrick, F. E., Valdiviezo, C., Wolinsky, C., Rudge, J. S., Wiegand, S. J., Fuster, V., Badimon, J. J., and Sauter, B. V. (2004) Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 110, 2430-2435
39. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439
40. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66